ABPWW
Abpro Holdings Inc - Warrants (12/11/2029) (ABPWW)
NASDAQ • $0.010.00%
- Symbol
- ABPWW
- Exchange
- NASDAQ
- Sector
- Industry
- Price
- $0.01
- Daily Change
- 0.00%
- Market Cap
- N/A
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $0.01
- 52W Low
- $0.01
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 0.01
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inh…
Company websiteResearch ABPWW on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.